Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard's lead asset AT-108 into Phase 1 clinical development -- AT-108 is a transformative immunotherapy that ...
Nantes, France, April 15, 2026 - 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage ...
Treatment represents a new approach that could potentially restore brain cells lost due to Parkinson’s disease ...
GLP-1 generics enter the world’s diabetes capital and are added to bridal packages to cut ‘food noise’; can they fix India's ...
Republic Act (RA) 12316—was signed on March 25, 2026 by President Ferdinand Marcos, Jr. This law created a conditional, ...
Morning Overview on MSN
DNA-based system targets cancer cells and releases drugs at tumors
Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a ...
Wealthy Driver on MSN
You’re not crazy: Car repairs really have become harder to price
If you’ve looked at a repair estimate lately and thought the numbers seemed strangely slippery, you’re not imagining things. Modern vehicles are more complicated than they used to be, and even fairly ...
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning or switching from milk to solid food in early life doesn't just change what ...
BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...
John is a writer at Pocket-lint. He is passionate about all things technology, and is always keeping up with the latest smartphone and PC releases. John has previously written at MobileSyrup. When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results